Oppenheimer Issues Pessimistic Forecast for Integral Ad Science (NASDAQ:IAS) Stock Price

Integral Ad Science (NASDAQ:IAS - Get Free Report) had its price objective reduced by Oppenheimer from $20.00 to $18.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Oppenheimer's target price would suggest a potential upside of 66.82% from the company's current price.

Other research analysts also recently issued reports about the company. Barclays boosted their target price on Integral Ad Science from $12.00 to $13.00 and gave the stock an "equal weight" rating in a research note on Monday, August 5th. Morgan Stanley boosted their price objective on Integral Ad Science from $12.00 to $13.00 and gave the company an "equal weight" rating in a report on Tuesday, July 23rd. Benchmark reissued a "hold" rating on shares of Integral Ad Science in a report on Monday, August 5th. Finally, Raymond James boosted their price objective on Integral Ad Science from $13.00 to $15.00 and gave the company an "outperform" rating in a report on Friday, August 2nd. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $15.70.

Integral Ad Science Stock Down 14.5 %

Shares of NASDAQ:IAS traded down $1.83 on Wednesday, reaching $10.79. The company had a trading volume of 2,135,399 shares, compared to its average volume of 1,391,874. Integral Ad Science has a 52-week low of $7.98 and a 52-week high of $17.53. The firm's 50 day simple moving average is $11.13 and its 200-day simple moving average is $10.46. The firm has a market capitalization of $1.74 billion, a PE ratio of 55.00, a PEG ratio of 1.90 and a beta of 1.52. The company has a current ratio of 3.76, a quick ratio of 3.76 and a debt-to-equity ratio of 0.10.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.52% and a net margin of 6.39%. The business had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. During the same period last year, the business posted ($0.09) EPS. The business's revenue was up 11.0% compared to the same quarter last year. As a group, analysts expect that Integral Ad Science will post 0.23 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Tania Secor sold 5,240 shares of the company's stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the sale, the chief financial officer now directly owns 248,223 shares in the company, valued at $2,509,534.53. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the transaction, the chief executive officer now directly owns 239,709 shares in the company, valued at approximately $2,423,457.99. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Tania Secor sold 5,240 shares of the stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the transaction, the chief financial officer now owns 248,223 shares of the company's stock, valued at $2,509,534.53. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 23,006 shares of company stock worth $240,296 over the last ninety days. Corporate insiders own 2.00% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. nVerses Capital LLC acquired a new stake in shares of Integral Ad Science in the third quarter valued at $45,000. Ameritas Investment Partners Inc. raised its stake in shares of Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company's stock valued at $67,000 after acquiring an additional 1,924 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of Integral Ad Science in the third quarter valued at $106,000. Stoneridge Investment Partners LLC acquired a new stake in shares of Integral Ad Science in the third quarter valued at $125,000. Finally, XTX Topco Ltd acquired a new stake in Integral Ad Science in the second quarter valued at $113,000. 95.78% of the stock is currently owned by institutional investors and hedge funds.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.